Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors.
about
Induction of a novel cellular homolog of interleukin-10, AK155, by transformation of T lymphocytes with herpesvirus saimiriUse of a recombinant Salmonella enterica serovar Typhimurium strain expressing C-Raf for protection against C-Raf induced lung adenoma in miceInterleukin-10 plays an early role in generating virus-specific T cell anergy.Retroviral infection in vivo requires an immune escape virulence factor encrypted in the envelope protein of oncoretroviruses.Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8(+) cytotoxic T lymphocytes.Dendritic cells: immunological sentinels with a central role in health and disease.DNA-based vaccines activate innate and adaptive antitumor immunity by engaging the NKG2D receptor.Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus.Local delivery of the viral interleukin-10 gene suppresses tissue inflammation in murine Pneumocystis carinii infection.Epstein-Barr virus and oncogenesis: from latent genes to tumours.Epstein-Barr virus IL-10 gene expression by a recombinant murine gammaherpesvirus in vivo enhances acute pathogenicity but does not affect latency or reactivation.The Staphylococcus aureus Map protein is an immunomodulator that interferes with T cell-mediated responsesAltered cutaneous immune parameters in transgenic mice overexpressing viral IL-10 in the epidermisHuman, viral or mutant human IL-10 expressed after local adenovirus-mediated gene transfer are equally effective in ameliorating disease pathology in a rabbit knee model of antigen-induced arthritis.Oncogenic gamma-herpesviruses: comparison of viral proteins involved in tumorigenesis.A DNA-based cancer vaccine enhances lymphocyte cross talk by engaging the NKG2D receptor.The Microbiome, Systemic Immune Function, and Allotransplantation.RNAs in Epstein-Barr virions control early steps of infection.Interleukin 10 secretion in relation to human IL-10 locus haplotypes.Interleukin-10 and the immune response against cancer: a counterpoint.Placental syncytins: Genetic disjunction between the fusogenic and immunosuppressive activity of retroviral envelope proteins.A single amino acid determines the immunostimulatory activity of interleukin 10.Altered immune responses in interleukin 10 transgenic mice.Improving T cell therapy for cancer.Interleukin 10 (IL-10): an immunosuppressive factor and independent predictor in patients with metastatic renal cell carcinoma.Tumor cells expressing a retroviral envelope escape immune rejection in vivoA placenta-specific receptor for the fusogenic, endogenous retrovirus-derived, human syncytin-2.Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10)PEG-rIL-10 treatment decreases FoxP3(+) Tregs despite upregulation of intratumoral IDODual biological effects of the cytokines interleukin-10 and interferon-γ.IL-10 stimulatory effects on human NK cells explored by gene profile analysis.Structure-based release analysis of the JC virus agnoprotein regions: A role for the hydrophilic surface of the major alpha helix domain in release.Manipulation of the host cell membrane by human γ-herpesviruses EBV and KSHV for pathogenesis.Reduced tumorigenesis of EG7 after interleukin-10 gene transfer and enhanced efficacy in combination with intratumorally injection of adenovirus-mediated lymphotactin and the underlying mechanism.ICAM-1, soluble-CD23, and interleukin-10 concentrations in serum in renal-transplant recipients with Epstein-Barr virus reactivation.Human papillomavirus, Epstein-Barr virus, and methylation status of p16ink4a in penile cancer.Interleukin-10 ablation promotes tumor development, growth, and metastasis.Interleukin-10 promotes B16-melanoma growth by inhibition of macrophage functions and induction of tumour and vascular cell proliferation.The cytokine microenvironment of human colon carcinoma. Lymphocyte expression of tumor necrosis factor-alpha and interleukin-4 predicts improved survival.Paralysis of B7 co-stimulation through the effect of viral IL-10 on T cells as a mechanism of local tolerance induction.
P2860
Q22253378-A7249FAB-07CF-4D3E-AFE6-993123A51569Q24806827-D52E2974-D067-4905-AF84-8BF05A0A8181Q33287802-24A93039-C6D6-4B41-9B2B-EAA1BD15BF79Q33734859-68438FC0-53F6-48A9-8E8C-F950102164AFQ33804742-13784962-C243-42D6-9072-A246F4A9016CQ33890355-1BBBB80A-A161-48DD-9566-5372066D6214Q33911460-6FEFB26D-F9CA-4388-B3AF-B4BA5B83EE78Q33993288-1D64001C-D9BD-47EC-B013-75979CD18AC0Q34185923-29AFBD06-6B11-4A24-976B-C1E498ED4AE9Q34221194-F5790674-D9C7-443F-AAA8-12D5D8106B12Q34352574-DE452AE1-D8F8-4997-93D6-2D31E619B7BCQ34826413-760D9A42-4507-435A-BADC-BA20EBCAAB3CQ35095510-52A51EF4-B274-45BF-95FD-B39F1C42FFB1Q35605628-6CB4C187-793F-452B-BBB0-14B415F7CF1AQ35841060-CB6E969E-26CA-43DD-8CD2-10B1F6BAB496Q35849588-160E6117-BC05-4B38-B687-52173AC95658Q35866187-EC2E777A-426F-4E97-B6F4-6E9E474FD02AQ35991530-D76EB4E1-4307-4CF6-8788-925E3F82FF4CQ36261673-8CEC7514-2756-40F7-BD50-4C5C57F68023Q36276594-411A50C7-6F58-450A-ADA6-0E05425EA008Q36300087-D82611D1-4608-4A42-B4C9-D3563E766FB0Q36375705-57F3A501-8F53-40CA-AB55-70D01C1D6FBDQ36377330-B6EC3573-9B26-4AF0-BD55-64788DBE126CQ36407236-B20A1740-A30A-414D-B50E-AA623B4D9369Q36617525-286AAB82-B77D-4F63-B72C-F3C847EFE634Q36758070-06BD9510-4E95-4025-82F0-17AC93514006Q36971073-8C6D0800-902A-48B0-ACC2-223FAA553F74Q37113833-6C7D9C54-24EA-411E-B3BF-C7D940C39A6CQ37222162-25BF9CE6-7EB6-4AA4-9E8C-51E4768153F6Q37932437-515D610F-624C-4767-BA31-7CEE4CB0053BQ38333675-179BE1D3-DD59-40F3-A5E9-392765D70D73Q38672601-C1247D36-8B31-46D0-B37C-37FA664824FFQ38953504-3A0F1CA4-A658-4FAB-BAF2-00D6F0FA32F1Q39607063-42C061B7-1F4C-4780-AD10-60E29A3F0581Q39811512-C296AAD4-5B65-4693-A37D-D3A8002E260EQ40245504-B3D0553F-C9E5-4370-A226-7FBAF295124DQ40507111-351AF497-3791-46FE-9EAB-ADD8C34ECB23Q40747726-30B7F36F-FB8A-407E-BD16-9E150C0CF666Q40926542-02343899-EE50-4935-8C98-B0866EBF3478Q40990067-895AEBAE-C77D-410F-8251-6017386A8502
P2860
Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Viral interleukin 10 (IL-10), ...... logeneic and syngeneic tumors.
@ast
Viral interleukin 10 (IL-10), ...... logeneic and syngeneic tumors.
@en
type
label
Viral interleukin 10 (IL-10), ...... logeneic and syngeneic tumors.
@ast
Viral interleukin 10 (IL-10), ...... logeneic and syngeneic tumors.
@en
prefLabel
Viral interleukin 10 (IL-10), ...... logeneic and syngeneic tumors.
@ast
Viral interleukin 10 (IL-10), ...... logeneic and syngeneic tumors.
@en
P2093
P2860
P356
P1476
Viral interleukin 10 (IL-10), ...... logeneic and syngeneic tumors.
@en
P2093
P2860
P304
P356
10.1084/JEM.182.2.477
P407
P577
1995-08-01T00:00:00Z